← Back to Search
Prognostic Value Of Fat Mass And Skeletal Muscle Mass Determined By Computed Tomography In Patients Who Underwent Transcatheter Aortic Valve Implantation.
M. Mok, R. Allende, J. Leipsic, O. Altisent, María del Trigo, F. Campelo-Parada, R. Delarochelliére, É. Dumont, D. Doyle, M. Côté, Melanie R. Freeman, J. Webb, J. Rodés-Cabau
Published 2016 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Body composition (fat mass [FM] and skeletal muscle mass [SMM]) predicts clinical outcomes. In particular, loss of SMM (sarcopenia) is associated with frailty and mortality. There are no data on the prevalence and impact of FM and SMM in patients undergoing transcatheter aortic valve implantation (TAVI). The objective of this study is to determine body composition from pre-TAVI computed tomography (CT) and evaluate its association with clinical outcomes in patients who underwent TAVI. A total of 460 patients (mean age 81 ± 8 years, men: 51%) were included. Pre-TAVI CTs of the aorto-ilio-femoral axis were analyzed for FM and SMM cross-sectional area at the level of the third lumbar vertebrae (L3). Regression equations correlating cross-sectional area at L3 to total body FM and SMM were used to determine prevalence of sarcopenia, obesity, and sarcopenic obesity in patients (64%, 65%, and 46%, respectively). Most TAVI procedures were performed through a transfemoral approach (59%) using a balloon-expandable valve (94%). The 30-day and mid-term (median 12 months [interquartile range 6 to 27]) mortality rates were 6.1% and 29.6%, respectively. FM had no association with clinical outcomes, but sarcopenia predicted cumulative mortality (hazard ratio 1.55, 95% confidence interval 1.02 to 2.36, p = 0.04). In conclusion, body composition analysis from pre-TAVI CT is feasible. Sarcopenia, obesity, and sarcopenic obesity are prevalent in the TAVI population, with sarcopenia predictive of cumulative mortality.
This paper references
Human body composition: advances in models and methods.
S. Heymsfield (1997)
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.
P. Green (2012)
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.
M. Mourtzakis (2008)
The obesity paradox: body mass index and outcomes in patients with heart failure.
J. Curtis (2005)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
C. Prado (2008)
Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation.
S. Stortecky (2012)
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.
R. Fielding (2011)
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.
K. Marquis (2002)
Body composition: why, when and for who?
R. Thibault (2012)
Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery.
M. Visser (2013)
Appendicular skeletal muscle mass: effects of age, gender, and ethnicity.
D. Gallagher (1997)
Epidemiology of sarcopenia among the elderly in New Mexico.
R. Baumgartner (1998)
The cardiometabolic syndrome and sarcopenic obesity in older persons.
L. Dominguez (2007)
European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people
A. Cruz-Jentoft (2010)
Sarcopenia: European consensus on definition and diagnosis
A. Cruz-Jentoft (2010)
Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial
Suzanne V. Arnold (2014)
Clinical survival predictors in patients with advanced cancer.
A. Viganò (2000)
Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients.
S. O’Connor (2015)
Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly.
R. Baumgartner (2004)
Transcatheter aortic valve implantation: current and future approaches
J. Rodés-Cabau (2012)
Sarcopenia: Diagnosis and treatment
J. Morley (2008)
Sarcopenia and Physical Frailty: Two Sides of the Same Coin
M. Cesari (2014)
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.
T. Lancefield (2010)
Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr.
I. Janssen (2000)
Sarcopenia: origins and clinical relevance.
I. H. Rosenberg (2011)
Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement.
J. Webb (2012)
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score
B. Iung (2014)
Sarcopenia and mortality among older nursing home residents.
F. Landi (2012)
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
C. Lavie (2009)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.
D. Holmes (2012)
Sarcopenic obesity: definition, cause and consequences
S. Stenholm (2008)
This paper is referenced by
Prognostic value of sarcopenic obesity estimated by computed tomography in patients with cardiovascular disease and undergoing surgery.
M. Yamashita (2019)
Prognostic Value of Psoas Muscle Area and Density in Patients Who Undergo Cardiovascular Surgery.
M. Yamashita (2017)
Prevalence and Prognostic Implications of Frailty in Transcatheter Aortic Valve Replacement.
P. Piankova (2020)
Fully Automated Segmentation of Connective Tissue Compartments for CT-Based Body Composition Analysis
Sebastian Nowak (2020)
Implications of low muscle mass across the continuum of care: a narrative review
C. Prado (2018)
Prognostic Usefulness of Arm and Calf Circumference in Patients ≥65 Years of Age With Cardiovascular Disease.
K. Kamiya (2017)
Transcatheter aortic valve replacement outcomes in mixed aortic valve disease compared to predominant aortic stenosis.
B. Heidari (2019)
Transcatheter aortic valve replacement outcomes in patients with sarcopaenia
M. Al-Hijji (2019)
Usefulness of Psoas Muscle Area and Volume and Frailty Scoring to Predict Outcomes After Transcatheter Aortic Valve Implantation.
Pawel Kleczynski (2018)
Sarcopenia in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): A Systematic Review of the Literature
Dominic Bertschi (2020)
The impact of preoperative sarcopenia, defined based on psoas muscle area, on long‐term outcomes of heart valve surgery
H. Okamura (2018)
Is sarcopenia a useful predictor of outcome in patients after emergency laparotomy? A study using the NELA database
J. Trotter (2018)
Computed Tomography–based Body Composition Analysis and Its Role in Lung Cancer Care
Amelie S Troschel (2019)
Usefulness of skeletal muscle area detected by computed tomography to predict mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis study
Mohamad Soud (2019)
Hospital-Acquired Functional Decline and Clinical Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Implantation.
M. Saitoh (2020)
Albumin Is Predictive of 1-Year Mortality After Transcatheter Aortic Valve Replacement.
Katherine R. Hebeler (2018)
Clinical Outcomes of Subcutaneous and Visceral Adipose Tissue Characteristics Assessed in Patients Underwent Transcatheter Aortic Valve Replacement
K. Shibata (2021)
A sex-specific evaluation of predicted lean and fat mass composition and cardiovascular disease onset and progression: A combined analysis of the ATTICA and GREECS prospective epidemiological studies.
M. Kouvari (2019)
Effect of body mass index on clinical outcome and all-cause mortality in patients undergoing transcatheter aortic valve implantation
M. Abawi (2017)
Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement.
Abdulla A Damluji (2020)
Diagnosing Sarcopenia on Thoracic Computed Tomography: Quantitative Assessment of Skeletal Muscle Mass in Patients Undergoing Transcatheter Aortic Valve Replacement.
U. Nemec (2017)
Prognostic Impact of Low Skeletal Muscle Mass on Major Adverse Cardiovascular Events in Coronary Artery Disease: A Propensity Score-Matched Analysis of a Single Center All-Comer Cohort
D. O. Kang (2019)
Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
Vishal Dahya (2016)
Conceptual Models of Frailty: The Sarcopenia Phenotype.
J. Afilalo (2016)
Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement
H. Hioki (2018)
Importance of combined assessment of skeletal muscle mass and density by computed tomography in predicting clinical outcomes after transcatheter aortic valve replacement
T. Tokuda (2020)
Usefulness of Thoracic Aortic Calcium to Predict 1-Year Mortality after Transcatheter Aortic Valve Implantation.
Mohanad Hamandi (2020)
Effects of sarcopenia on functional improvement over the first year after cardiac surgery: a cohort study
Chiao-Hsin Teng (2019)
Computed Tomography Assessment for Transcatheter Aortic Valve Replacement.
M. Alkhouli (2018)
Transcatheter Aortic Valve Replacement in the Care of Older Persons with Aortic Stenosis
C. Talbot-Hamon (2017)
Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.
Yong-Hoon Yoon (2020)
Sarcopaenia in surgical populations: A review.
Rachel S M Heard (2017)See more